Figures & data
Figure 1. Overview of the stepwise approach to identify, validate and possibly incorporate PGx biomarkers into routine clinical practice based on individualized HU drug treatment response
Expert Review of Hematology
Volume 14, 2021 - Issue 10
Editorial
Strategies to improve pharmacogenomic-guided treatment options for patients with β-hemoglobinopathies
George P. Patrinosa School of Health Sciences, Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras, Patras, Greece;b College of Medicine and Health Sciences, Department of Pathology, United Arab Emirates University, Al-Ain, UAE;c Zayed Center of Health Sciences, United Arab Emirates University, Al-Ain, UAECorrespondence[email protected]
https://orcid.org/0000-0002-0519-7776View further author information
https://orcid.org/0000-0002-0519-7776View further author information, , & Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.